Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a top Novartis official warned Friday in […] Continue reading ->
Nairobi, Kenya (6 December 2019) – An International Conference on Neglected Tropical Diseases (NTDs) ended in Nairobi on Friday with calls for increased research, resources and strengthened cross border partnerships to accelerate the elimination of the diseases. The three day inaugural conference in Africa brought together some 230 participants including scientists, researchers, policy makers and […] Continue reading ->
The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading ->
Madrid – Exceptional global heat waves, retreating ice sheets and record sea levels – all driven by rising concentrations of atmospheric greenhouse gases – are the hallmark of the past decade as 2019 draws to a close, said the World Metereological Organization (WMO) on Tuesday. The global average temperature in 2019 (January to October) was […] Continue reading ->
For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines.  This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading ->
[Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading ->